Trenbolone hexahydrobenzylcarbonate
Clinical data | |
---|---|
Trade names | Parabolan, Hexabolan |
Other names | Trenbolone cyclohexylmethylcarbonate; Estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.041.503 |
Chemical and physical data | |
Formula | C26H34O4 |
Molar mass | 410.554 g·mol−1 |
3D model (JSmol) | |
| |
|
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.[1]
It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997.[1][2] The drug acts as a long-lasting prodrug of trenbolone when administered via intramuscular injection.[1] It was used clinically at a dosage of one ampoule (76 mg, corresponding to 50 mg trenbolone base) every 10 days.[1]
See also
References
- ^ a b c d William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 619–. ISBN 978-0-9828280-1-4.
- ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 3307–. ISBN 978-0-8155-1856-3.
Further reading
- Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi:10.1016/j.steroids.2010.01.019. PMID 20138077. S2CID 205253265.
External links
- Trenbolone Hexahydrobenzylcarbonate - William Llewellyn's Anabolic.org Archived 2016-04-07 at the Wayback Machine
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
ARTooltip Androgen receptor |
| ||||||
---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||
PRTooltip Progesterone receptor |
| ||||||
---|---|---|---|---|---|---|---|
mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) |
| ||||||
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- Articles with short description
- Short description matches Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Webarchive template wayback links
- Abandoned drugs
- Androgen esters
- Anabolic–androgenic steroids
- Carbonate esters
- Estranes
- Ketones
- Prodrugs
- Progestogens
- All stub articles
- Steroid stubs
- Genito-urinary system drug stubs
- Gastrointestinal system drug stubs